English

    Overview

  • Dr. Ambanna Gowda is a highly accomplished medical professional in Bangalore currently practising as a Consultant, Internal Medicine at Manipal Hospital Old Airport Road, Bangalore. With a rich academic and clinical experience, Dr. Gowda is recognised for his expertise in preventive healthcare, diabetes, and managing a wide array of medical conditions, including COVID-19, hypertension, thyroid disorders, and pregnancy-related issues. His journey in the medical sector began with his MBBS from Mahadevappa Rampure Medical College (MRMC), Gulbarga in 2005, followed by an MD in General Medicine from Dr. B R Ambedkar Medical College, Bangalore, in 2010. He furthered his specialisation in diabetes by completing a Fellowship at MV Diabetes Research Centre, Chennai, and a PG Diploma in Diabetes from Cardiff University, UK. Dr. Ambanna Gowda also pursued a Diabetology and Advanced Diabetology Course from Steno Diabetes Centre, Copenhagen, Denmark, to enhance his skills even more in managing diabetes-related complications. He is the Best Internal Medicine Doctor in Bangalore, Old Airport Road.

  • Throughout his career, Dr. Ambanna Gowda has held significant positions in both academic and clinical settings. He is an International Advisory Board Member for Hutchinson’s Clinical Methods textbook. He also served as an Assistant Professor in the Department of General Medicine at Dr. B R Ambedkar Medical College, Bangalore. Dr. Gowda’s clinical expertise extends beyond routine patient care. He is proficient in advanced medical procedures and therapeutic interventions, including advanced airway and ICU management. Dr. Gowda possesses exceptional skills in diagnosing illnesses and prescribing appropriate treatments tailored to individual patient needs. His dedication to the well-being of society has earned him the invitation to “Doctor’s Day Enclave” by the Economic Times where he was featured in the coffee table book “The Economic Times: Inspiring Doctors of India 2023”. 

  • In addition to his clinical responsibilities, Dr. Ambanna Gowda actively contributes to medical research and academic endeavours. He has authored and co-authored numerous publications in international journals, focusing on various aspects of medical research, including diabetes management, infectious diseases, and critical care. “Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes with RyzodegTM Treatment)”, “An Elusive case of acute abdomen in dengue fever”, and “Prevalence of nosocomial infections in the intensive care unit” are some of Dr. Gowda’s notable publications.

  • Dr. Ambanna Gowda's commitment to advancing medical knowledge is evident through his participation in scientific programmes, presentations, and conferences, where he shares insights and experiences with peers in the medical field. Dr. Ambanna Gowda's dedication to patient care, combined with his academic achievements and research contributions, underscores his role as a respected internal medicine doctor in Bangalore who is committed to improving the health and well-being of individuals in his community and beyond. 

  • Field of Expertise

  • Preventive healthcare
  • Diabetes
  • COVID-19 and related complications
  • Hypertension
  • Thyroid disorders
  • Pregnancy-related medical conditions
  • Fellowship & Membership

  • Fellowship In Diabetes
  • M V Diabetes Centre, Chennai.
  • (PG Dip Diabetes), Cardiff UK
  • Languages Spoken

  • Kannada
  • English
  • Hindi
  • Telugu
  • Talks & Publications

  • Reviewer of chapters / Member IAB (International Advisory Board) for the new edition 24th Edition Hutchinson’s clinical textbook.
  • Reviewer of journals, Karnataka :
  • Journal of Evolution of Medical and Dental Sciences. https://www.jemds.com/index
  • Journal of Evidence-Based Medicine and Healthcare.https://www.jebmh.com
  • THESIS TOPIC:
  • As a part of M.D. Degree course, dissertation titled “A Study on Prevalence of Nosocomial Infections in the Intensive Care Unit Patients at DR.B.R. Ambedkar Medical College and Teaching Hospital” has been accepted by R.G.U.H.S, Bangalore.
  • PI A randomized, international, multicenter double-blind study to compare the efficacy,
  • safety, and immunogenicity of PZN-128 powder for solution for subcutaneous injection 250 μg
  • (Pharmasyntez- Nord JSC, Russia) versus сomparator drug in patients with chronic idiopathic
  • (immune) thrombocytopenic purpura.
  • Principal investigator PHASE II study An open-label, randomized, single-dose,two-treatment, two-way crossover, oral bioavailability study of an investigational product containing glutathione, in healthy, adult, human subjects under fasting conditions.
  • Principal investigator phase 2 study An open-label randomized, single dose two treatment, two-way crossover oral bioavailability study of investigational products in healthy adult human participants under fasting conditions.
  • Principal Investigator A Double-blind, Randomized, Comparative Clinical Study to Evaluate The
  • Safety And Efficacy Of Study Drug for Iron Repletion In Adult Male Or Female Patients Suffering With Iron Deficiency Anemia As Supplement/Adjuvant To The Treatment.
  • Principal Investigators A Multicentric, Phase IV Clinical Trial to Evaluate Safety and Efficacy of Fixed
  • Dose Combination of Carvedilol and Ivabradine Hydrochloride Tablet as a Substitution Therapy in
  • Patients of Stable Chronic Heart Failure (CHF) with Systolic Dysfunction or Patients of Stable Chronic Angina Pectoris.
  • Principal Investigator A Randomized, Double-Blind, Multicenter, Parallel Group Study to Compare
  • Efficacy Safety, Immunogenicity, Pharmacokinetics and Pharmacodynamics of BP08 (Tocilizumab) and RoActemra® in patients with moderate to severe Rheumatoid Arthritis (RA) with inadequate response to Methotrexate

    Fellowship & Membership

  • Fellowship In Diabetes
  • M V Diabetes Centre, Chennai.
  • (PG Dip Diabetes), Cardiff UK
  • Overview

  • Dr. Ambanna Gowda is a highly accomplished medical professional in Bangalore currently practising as a Consultant, Internal Medicine at Manipal Hospital Old Airport Road, Bangalore. With a rich academic and clinical experience, Dr. Gowda is recognised for his expertise in preventive healthcare, diabetes, and managing a wide array of medical conditions, including COVID-19, hypertension, thyroid disorders, and pregnancy-related issues. His journey in the medical sector began with his MBBS from Mahadevappa Rampure Medical College (MRMC), Gulbarga in 2005, followed by an MD in General Medicine from Dr. B R Ambedkar Medical College, Bangalore, in 2010. He furthered his specialisation in diabetes by completing a Fellowship at MV Diabetes Research Centre, Chennai, and a PG Diploma in Diabetes from Cardiff University, UK. Dr. Ambanna Gowda also pursued a Diabetology and Advanced Diabetology Course from Steno Diabetes Centre, Copenhagen, Denmark, to enhance his skills even more in managing diabetes-related complications. He is the Best Internal Medicine Doctor in Bangalore, Old Airport Road.

  • Throughout his career, Dr. Ambanna Gowda has held significant positions in both academic and clinical settings. He is an International Advisory Board Member for Hutchinson’s Clinical Methods textbook. He also served as an Assistant Professor in the Department of General Medicine at Dr. B R Ambedkar Medical College, Bangalore. Dr. Gowda’s clinical expertise extends beyond routine patient care. He is proficient in advanced medical procedures and therapeutic interventions, including advanced airway and ICU management. Dr. Gowda possesses exceptional skills in diagnosing illnesses and prescribing appropriate treatments tailored to individual patient needs. His dedication to the well-being of society has earned him the invitation to “Doctor’s Day Enclave” by the Economic Times where he was featured in the coffee table book “The Economic Times: Inspiring Doctors of India 2023”. 

  • In addition to his clinical responsibilities, Dr. Ambanna Gowda actively contributes to medical research and academic endeavours. He has authored and co-authored numerous publications in international journals, focusing on various aspects of medical research, including diabetes management, infectious diseases, and critical care. “Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes with RyzodegTM Treatment)”, “An Elusive case of acute abdomen in dengue fever”, and “Prevalence of nosocomial infections in the intensive care unit” are some of Dr. Gowda’s notable publications.

  • Dr. Ambanna Gowda's commitment to advancing medical knowledge is evident through his participation in scientific programmes, presentations, and conferences, where he shares insights and experiences with peers in the medical field. Dr. Ambanna Gowda's dedication to patient care, combined with his academic achievements and research contributions, underscores his role as a respected internal medicine doctor in Bangalore who is committed to improving the health and well-being of individuals in his community and beyond. 

  • Field of Expertise

  • Preventive healthcare
  • Diabetes
  • COVID-19 and related complications
  • Hypertension
  • Thyroid disorders
  • Pregnancy-related medical conditions
  • Languages Spoken

  • Kannada
  • English
  • Hindi
  • Telugu
  • Talks & Publications

  • Reviewer of chapters / Member IAB (International Advisory Board) for the new edition 24th Edition Hutchinson’s clinical textbook.
  • Reviewer of journals, Karnataka :
  • Journal of Evolution of Medical and Dental Sciences. https://www.jemds.com/index
  • Journal of Evidence-Based Medicine and Healthcare.https://www.jebmh.com
  • THESIS TOPIC:
  • As a part of M.D. Degree course, dissertation titled “A Study on Prevalence of Nosocomial Infections in the Intensive Care Unit Patients at DR.B.R. Ambedkar Medical College and Teaching Hospital” has been accepted by R.G.U.H.S, Bangalore.
  • PI A randomized, international, multicenter double-blind study to compare the efficacy,
  • safety, and immunogenicity of PZN-128 powder for solution for subcutaneous injection 250 μg
  • (Pharmasyntez- Nord JSC, Russia) versus сomparator drug in patients with chronic idiopathic
  • (immune) thrombocytopenic purpura.
  • Principal investigator PHASE II study An open-label, randomized, single-dose,two-treatment, two-way crossover, oral bioavailability study of an investigational product containing glutathione, in healthy, adult, human subjects under fasting conditions.
  • Principal investigator phase 2 study An open-label randomized, single dose two treatment, two-way crossover oral bioavailability study of investigational products in healthy adult human participants under fasting conditions.
  • Principal Investigator A Double-blind, Randomized, Comparative Clinical Study to Evaluate The
  • Safety And Efficacy Of Study Drug for Iron Repletion In Adult Male Or Female Patients Suffering With Iron Deficiency Anemia As Supplement/Adjuvant To The Treatment.
  • Principal Investigators A Multicentric, Phase IV Clinical Trial to Evaluate Safety and Efficacy of Fixed
  • Dose Combination of Carvedilol and Ivabradine Hydrochloride Tablet as a Substitution Therapy in
  • Patients of Stable Chronic Heart Failure (CHF) with Systolic Dysfunction or Patients of Stable Chronic Angina Pectoris.
  • Principal Investigator A Randomized, Double-Blind, Multicenter, Parallel Group Study to Compare
  • Efficacy Safety, Immunogenicity, Pharmacokinetics and Pharmacodynamics of BP08 (Tocilizumab) and RoActemra® in patients with moderate to severe Rheumatoid Arthritis (RA) with inadequate response to Methotrexate

    Languages Spoken

  • Kannada
  • English
  • Hindi
  • Telugu
  • Overview

  • Dr. Ambanna Gowda is a highly accomplished medical professional in Bangalore currently practising as a Consultant, Internal Medicine at Manipal Hospital Old Airport Road, Bangalore. With a rich academic and clinical experience, Dr. Gowda is recognised for his expertise in preventive healthcare, diabetes, and managing a wide array of medical conditions, including COVID-19, hypertension, thyroid disorders, and pregnancy-related issues. His journey in the medical sector began with his MBBS from Mahadevappa Rampure Medical College (MRMC), Gulbarga in 2005, followed by an MD in General Medicine from Dr. B R Ambedkar Medical College, Bangalore, in 2010. He furthered his specialisation in diabetes by completing a Fellowship at MV Diabetes Research Centre, Chennai, and a PG Diploma in Diabetes from Cardiff University, UK. Dr. Ambanna Gowda also pursued a Diabetology and Advanced Diabetology Course from Steno Diabetes Centre, Copenhagen, Denmark, to enhance his skills even more in managing diabetes-related complications. He is the Best Internal Medicine Doctor in Bangalore, Old Airport Road.

  • Throughout his career, Dr. Ambanna Gowda has held significant positions in both academic and clinical settings. He is an International Advisory Board Member for Hutchinson’s Clinical Methods textbook. He also served as an Assistant Professor in the Department of General Medicine at Dr. B R Ambedkar Medical College, Bangalore. Dr. Gowda’s clinical expertise extends beyond routine patient care. He is proficient in advanced medical procedures and therapeutic interventions, including advanced airway and ICU management. Dr. Gowda possesses exceptional skills in diagnosing illnesses and prescribing appropriate treatments tailored to individual patient needs. His dedication to the well-being of society has earned him the invitation to “Doctor’s Day Enclave” by the Economic Times where he was featured in the coffee table book “The Economic Times: Inspiring Doctors of India 2023”. 

  • In addition to his clinical responsibilities, Dr. Ambanna Gowda actively contributes to medical research and academic endeavours. He has authored and co-authored numerous publications in international journals, focusing on various aspects of medical research, including diabetes management, infectious diseases, and critical care. “Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes with RyzodegTM Treatment)”, “An Elusive case of acute abdomen in dengue fever”, and “Prevalence of nosocomial infections in the intensive care unit” are some of Dr. Gowda’s notable publications.

  • Dr. Ambanna Gowda's commitment to advancing medical knowledge is evident through his participation in scientific programmes, presentations, and conferences, where he shares insights and experiences with peers in the medical field. Dr. Ambanna Gowda's dedication to patient care, combined with his academic achievements and research contributions, underscores his role as a respected internal medicine doctor in Bangalore who is committed to improving the health and well-being of individuals in his community and beyond. 

  • Fellowship & Membership

  • Fellowship In Diabetes
  • M V Diabetes Centre, Chennai.
  • (PG Dip Diabetes), Cardiff UK
  • Field of Expertise

  • Preventive healthcare
  • Diabetes
  • COVID-19 and related complications
  • Hypertension
  • Thyroid disorders
  • Pregnancy-related medical conditions
  • Talks & Publications

  • Reviewer of chapters / Member IAB (International Advisory Board) for the new edition 24th Edition Hutchinson’s clinical textbook.
  • Reviewer of journals, Karnataka :
  • Journal of Evolution of Medical and Dental Sciences. https://www.jemds.com/index
  • Journal of Evidence-Based Medicine and Healthcare.https://www.jebmh.com
  • THESIS TOPIC:
  • As a part of M.D. Degree course, dissertation titled “A Study on Prevalence of Nosocomial Infections in the Intensive Care Unit Patients at DR.B.R. Ambedkar Medical College and Teaching Hospital” has been accepted by R.G.U.H.S, Bangalore.
  • PI A randomized, international, multicenter double-blind study to compare the efficacy,
  • safety, and immunogenicity of PZN-128 powder for solution for subcutaneous injection 250 μg
  • (Pharmasyntez- Nord JSC, Russia) versus сomparator drug in patients with chronic idiopathic
  • (immune) thrombocytopenic purpura.
  • Principal investigator PHASE II study An open-label, randomized, single-dose,two-treatment, two-way crossover, oral bioavailability study of an investigational product containing glutathione, in healthy, adult, human subjects under fasting conditions.
  • Principal investigator phase 2 study An open-label randomized, single dose two treatment, two-way crossover oral bioavailability study of investigational products in healthy adult human participants under fasting conditions.
  • Principal Investigator A Double-blind, Randomized, Comparative Clinical Study to Evaluate The
  • Safety And Efficacy Of Study Drug for Iron Repletion In Adult Male Or Female Patients Suffering With Iron Deficiency Anemia As Supplement/Adjuvant To The Treatment.
  • Principal Investigators A Multicentric, Phase IV Clinical Trial to Evaluate Safety and Efficacy of Fixed
  • Dose Combination of Carvedilol and Ivabradine Hydrochloride Tablet as a Substitution Therapy in
  • Patients of Stable Chronic Heart Failure (CHF) with Systolic Dysfunction or Patients of Stable Chronic Angina Pectoris.
  • Principal Investigator A Randomized, Double-Blind, Multicenter, Parallel Group Study to Compare
  • Efficacy Safety, Immunogenicity, Pharmacokinetics and Pharmacodynamics of BP08 (Tocilizumab) and RoActemra® in patients with moderate to severe Rheumatoid Arthritis (RA) with inadequate response to Methotrexate

    Field of Expertise

  • Preventive healthcare
  • Diabetes
  • COVID-19 and related complications
  • Hypertension
  • Thyroid disorders
  • Pregnancy-related medical conditions
  • Fellowship & Membership

  • Fellowship In Diabetes
  • M V Diabetes Centre, Chennai.
  • (PG Dip Diabetes), Cardiff UK
  • Languages Spoken

  • Kannada
  • English
  • Hindi
  • Telugu
  • Talks & Publications

  • Reviewer of chapters / Member IAB (International Advisory Board) for the new edition 24th Edition Hutchinson’s clinical textbook.
  • Reviewer of journals, Karnataka :
  • Journal of Evolution of Medical and Dental Sciences. https://www.jemds.com/index
  • Journal of Evidence-Based Medicine and Healthcare.https://www.jebmh.com
  • THESIS TOPIC:
  • As a part of M.D. Degree course, dissertation titled “A Study on Prevalence of Nosocomial Infections in the Intensive Care Unit Patients at DR.B.R. Ambedkar Medical College and Teaching Hospital” has been accepted by R.G.U.H.S, Bangalore.
  • PI A randomized, international, multicenter double-blind study to compare the efficacy,
  • safety, and immunogenicity of PZN-128 powder for solution for subcutaneous injection 250 μg
  • (Pharmasyntez- Nord JSC, Russia) versus сomparator drug in patients with chronic idiopathic
  • (immune) thrombocytopenic purpura.
  • Principal investigator PHASE II study An open-label, randomized, single-dose,two-treatment, two-way crossover, oral bioavailability study of an investigational product containing glutathione, in healthy, adult, human subjects under fasting conditions.
  • Principal investigator phase 2 study An open-label randomized, single dose two treatment, two-way crossover oral bioavailability study of investigational products in healthy adult human participants under fasting conditions.
  • Principal Investigator A Double-blind, Randomized, Comparative Clinical Study to Evaluate The
  • Safety And Efficacy Of Study Drug for Iron Repletion In Adult Male Or Female Patients Suffering With Iron Deficiency Anemia As Supplement/Adjuvant To The Treatment.
  • Principal Investigators A Multicentric, Phase IV Clinical Trial to Evaluate Safety and Efficacy of Fixed
  • Dose Combination of Carvedilol and Ivabradine Hydrochloride Tablet as a Substitution Therapy in
  • Patients of Stable Chronic Heart Failure (CHF) with Systolic Dysfunction or Patients of Stable Chronic Angina Pectoris.
  • Principal Investigator A Randomized, Double-Blind, Multicenter, Parallel Group Study to Compare
  • Efficacy Safety, Immunogenicity, Pharmacokinetics and Pharmacodynamics of BP08 (Tocilizumab) and RoActemra® in patients with moderate to severe Rheumatoid Arthritis (RA) with inadequate response to Methotrexate
  • Overview

  • Dr. Ambanna Gowda is a highly accomplished medical professional in Bangalore currently practising as a Consultant, Internal Medicine at Manipal Hospital Old Airport Road, Bangalore. With a rich academic and clinical experience, Dr. Gowda is recognised for his expertise in preventive healthcare, diabetes, and managing a wide array of medical conditions, including COVID-19, hypertension, thyroid disorders, and pregnancy-related issues. His journey in the medical sector began with his MBBS from Mahadevappa Rampure Medical College (MRMC), Gulbarga in 2005, followed by an MD in General Medicine from Dr. B R Ambedkar Medical College, Bangalore, in 2010. He furthered his specialisation in diabetes by completing a Fellowship at MV Diabetes Research Centre, Chennai, and a PG Diploma in Diabetes from Cardiff University, UK. Dr. Ambanna Gowda also pursued a Diabetology and Advanced Diabetology Course from Steno Diabetes Centre, Copenhagen, Denmark, to enhance his skills even more in managing diabetes-related complications. He is the Best Internal Medicine Doctor in Bangalore, Old Airport Road.

  • Throughout his career, Dr. Ambanna Gowda has held significant positions in both academic and clinical settings. He is an International Advisory Board Member for Hutchinson’s Clinical Methods textbook. He also served as an Assistant Professor in the Department of General Medicine at Dr. B R Ambedkar Medical College, Bangalore. Dr. Gowda’s clinical expertise extends beyond routine patient care. He is proficient in advanced medical procedures and therapeutic interventions, including advanced airway and ICU management. Dr. Gowda possesses exceptional skills in diagnosing illnesses and prescribing appropriate treatments tailored to individual patient needs. His dedication to the well-being of society has earned him the invitation to “Doctor’s Day Enclave” by the Economic Times where he was featured in the coffee table book “The Economic Times: Inspiring Doctors of India 2023”. 

  • In addition to his clinical responsibilities, Dr. Ambanna Gowda actively contributes to medical research and academic endeavours. He has authored and co-authored numerous publications in international journals, focusing on various aspects of medical research, including diabetes management, infectious diseases, and critical care. “Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes with RyzodegTM Treatment)”, “An Elusive case of acute abdomen in dengue fever”, and “Prevalence of nosocomial infections in the intensive care unit” are some of Dr. Gowda’s notable publications.

  • Dr. Ambanna Gowda's commitment to advancing medical knowledge is evident through his participation in scientific programmes, presentations, and conferences, where he shares insights and experiences with peers in the medical field. Dr. Ambanna Gowda's dedication to patient care, combined with his academic achievements and research contributions, underscores his role as a respected internal medicine doctor in Bangalore who is committed to improving the health and well-being of individuals in his community and beyond. 

    Talks & Publications

  • Reviewer of chapters / Member IAB (International Advisory Board) for the new edition 24th Edition Hutchinson’s clinical textbook.
  • Reviewer of journals, Karnataka :
  • Journal of Evolution of Medical and Dental Sciences. https://www.jemds.com/index
  • Journal of Evidence-Based Medicine and Healthcare.https://www.jebmh.com
  • THESIS TOPIC:
  • As a part of M.D. Degree course, dissertation titled “A Study on Prevalence of Nosocomial Infections in the Intensive Care Unit Patients at DR.B.R. Ambedkar Medical College and Teaching Hospital” has been accepted by R.G.U.H.S, Bangalore.
  • PI A randomized, international, multicenter double-blind study to compare the efficacy,
  • safety, and immunogenicity of PZN-128 powder for solution for subcutaneous injection 250 μg
  • (Pharmasyntez- Nord JSC, Russia) versus сomparator drug in patients with chronic idiopathic
  • (immune) thrombocytopenic purpura.
  • Principal investigator PHASE II study An open-label, randomized, single-dose,two-treatment, two-way crossover, oral bioavailability study of an investigational product containing glutathione, in healthy, adult, human subjects under fasting conditions.
  • Principal investigator phase 2 study An open-label randomized, single dose two treatment, two-way crossover oral bioavailability study of investigational products in healthy adult human participants under fasting conditions.
  • Principal Investigator A Double-blind, Randomized, Comparative Clinical Study to Evaluate The
  • Safety And Efficacy Of Study Drug for Iron Repletion In Adult Male Or Female Patients Suffering With Iron Deficiency Anemia As Supplement/Adjuvant To The Treatment.
  • Principal Investigators A Multicentric, Phase IV Clinical Trial to Evaluate Safety and Efficacy of Fixed
  • Dose Combination of Carvedilol and Ivabradine Hydrochloride Tablet as a Substitution Therapy in
  • Patients of Stable Chronic Heart Failure (CHF) with Systolic Dysfunction or Patients of Stable Chronic Angina Pectoris.
  • Principal Investigator A Randomized, Double-Blind, Multicenter, Parallel Group Study to Compare
  • Efficacy Safety, Immunogenicity, Pharmacokinetics and Pharmacodynamics of BP08 (Tocilizumab) and RoActemra® in patients with moderate to severe Rheumatoid Arthritis (RA) with inadequate response to Methotrexate
  • Overview

  • Dr. Ambanna Gowda is a highly accomplished medical professional in Bangalore currently practising as a Consultant, Internal Medicine at Manipal Hospital Old Airport Road, Bangalore. With a rich academic and clinical experience, Dr. Gowda is recognised for his expertise in preventive healthcare, diabetes, and managing a wide array of medical conditions, including COVID-19, hypertension, thyroid disorders, and pregnancy-related issues. His journey in the medical sector began with his MBBS from Mahadevappa Rampure Medical College (MRMC), Gulbarga in 2005, followed by an MD in General Medicine from Dr. B R Ambedkar Medical College, Bangalore, in 2010. He furthered his specialisation in diabetes by completing a Fellowship at MV Diabetes Research Centre, Chennai, and a PG Diploma in Diabetes from Cardiff University, UK. Dr. Ambanna Gowda also pursued a Diabetology and Advanced Diabetology Course from Steno Diabetes Centre, Copenhagen, Denmark, to enhance his skills even more in managing diabetes-related complications. He is the Best Internal Medicine Doctor in Bangalore, Old Airport Road.

  • Throughout his career, Dr. Ambanna Gowda has held significant positions in both academic and clinical settings. He is an International Advisory Board Member for Hutchinson’s Clinical Methods textbook. He also served as an Assistant Professor in the Department of General Medicine at Dr. B R Ambedkar Medical College, Bangalore. Dr. Gowda’s clinical expertise extends beyond routine patient care. He is proficient in advanced medical procedures and therapeutic interventions, including advanced airway and ICU management. Dr. Gowda possesses exceptional skills in diagnosing illnesses and prescribing appropriate treatments tailored to individual patient needs. His dedication to the well-being of society has earned him the invitation to “Doctor’s Day Enclave” by the Economic Times where he was featured in the coffee table book “The Economic Times: Inspiring Doctors of India 2023”. 

  • In addition to his clinical responsibilities, Dr. Ambanna Gowda actively contributes to medical research and academic endeavours. He has authored and co-authored numerous publications in international journals, focusing on various aspects of medical research, including diabetes management, infectious diseases, and critical care. “Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes with RyzodegTM Treatment)”, “An Elusive case of acute abdomen in dengue fever”, and “Prevalence of nosocomial infections in the intensive care unit” are some of Dr. Gowda’s notable publications.

  • Dr. Ambanna Gowda's commitment to advancing medical knowledge is evident through his participation in scientific programmes, presentations, and conferences, where he shares insights and experiences with peers in the medical field. Dr. Ambanna Gowda's dedication to patient care, combined with his academic achievements and research contributions, underscores his role as a respected internal medicine doctor in Bangalore who is committed to improving the health and well-being of individuals in his community and beyond. 

  • Fellowship & Membership

  • Fellowship In Diabetes
  • M V Diabetes Centre, Chennai.
  • (PG Dip Diabetes), Cardiff UK
  • Field of Expertise

  • Preventive healthcare
  • Diabetes
  • COVID-19 and related complications
  • Hypertension
  • Thyroid disorders
  • Pregnancy-related medical conditions
  • Languages Spoken

  • Kannada
  • English
  • Hindi
  • Telugu